Modality of Adjuvant Radiotherapy and Chemotherapy for Stage Ⅲ Endometrial Cancer

Endometrial cancer is the most common gynecological malignancy affecting women's health. About 15% of the patients will have local late disease (stage III) with high risk of recurrence and tumor related mortality. There is a consensus that adjuvant radiochemotherapy is needed for stage Ⅲ endometrial cancer, but the best modality of radiochemotherapy is still uncertain. The retrospective data of our center showed that the sequential radiochemotherapy of "chemotherapy-radiotherapy-chemotherapy" in the "sanwich" mode could improve the survival outcome in patients with advanced endometrial cancer.

Trial Details

NCT ID
NCT04453904
Phase
NA
Sponsor
Peking University People's Hospital
Status
RECRUITING
Cancer Type
Uterine Cancer
Interventions
  • sequential radiochemotherapy in a "sanwich" mode
Locations (sample)
  • Beijing, Beijing Municipality, China|39.9075,116.39723

Key Eligibility Criteria

  • patients of primary treatment
  • All patients must have undertaken comprehensive staging operation(Surgery must have included a hysterectomy and bilateral salpingooophorectomy and …
  • Patients with endometrial adenocarcinoma confirmed by postoperative patholog.
  • All patients with Surgical Stage III endometrial carcinoma according to FIGO 2009 staging criteria.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Uterine Cancer Trials on Trialify →